Phadia Automation – The all-in-one Solution for Allergy and Autoimmune Testing
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
The Phadia range of instruments: Phadia 200, Phadia 250, and Phadia 2500, are the only automated systems available that offer both ImmunoCAP Allergy and EliA Autoimmune testing on the one platform.
Phadia 250 is the most widely used instrument across ANZ for allergy and autoimmunity and can process up to 60 results/hour with random access, continuous feed automation for optimal laboratory workflow.
Phadia 200 is a batch automated instrument for lower volume process of allergy and autoimmunity, still with the advantage of offering the full range of assays available.
Phadia 2500/2500E/2500EE are the high capacity range of instruments form Thermo Fisher which allow for flexible setup of your laboratory
- Phadia 2500 – dedicated allergy instrument with double allergy lines
- Phadia 2500E – combination allergy and EliA lines
- Phaida 2500EE – dedicated double EliA lines for maximum autoimmune processing
Thermo Fisher innovation allows for laboratories to benefit from a cost effective workflow solution with ready-to-use reagents and an efficient, flexible calibration system with one calibration curve per method stored for 28 days.
f
ImmunoCAP Specific IgE Tests
Worldwide gold standard in in vitro allergy diagnostics designed to aid providers in the diagnosis of allergic diseases including allergic asthma, allergic rhinitis, and food allergies, with more than 550 whole allergens and allergen mixes, and 100 allergen components available.
EliA Autoimmune Tests
Offer one of the broadest portfolios on the market, consisting of clinically relevant markers developed into the highest-quality tests to support in the diagnosis of autoimmune diseases, potentially improving patient outcomes. EliA antigens are developed and manufactured in the Thermo Fisher Centre of Excellence facility using the eukaryotic Sf9 expression system to produce recombinant antigens. Optimal balance of sensitivity and specificity enables clinicians to more accurately diagnose the patient. Thermo Fisher innovation allows for laboratories to benefit from a cost effective workflow solution with ready-to-use reagents and an efficient, flexible calibration system with one calibration curve per method stored for 28 days.
f
